WT1(235), a ninemer peptide derived from Wilms' tumor gene product, is a candidate peptide for the vaccination of HLA-A*0201-positive patients with hematopoietic malignancies

Int J Hematol. 2005 Dec;82(5):458-9. doi: 10.1532/IJH97.05107.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antigen Presentation / immunology*
  • Cancer Vaccines / immunology
  • Epitopes, T-Lymphocyte / immunology*
  • HLA-A Antigens / immunology*
  • HLA-A2 Antigen
  • Hematologic Neoplasms / immunology
  • Hematologic Neoplasms / therapy
  • Humans
  • K562 Cells
  • Oligopeptides / immunology*
  • T-Lymphocytes, Cytotoxic / immunology*
  • Vaccination / methods
  • WT1 Proteins / immunology*

Substances

  • Cancer Vaccines
  • Epitopes, T-Lymphocyte
  • HLA-A Antigens
  • HLA-A*02:01 antigen
  • HLA-A2 Antigen
  • Oligopeptides
  • WT1 Proteins